Integral Molecular News

Webinar presented by Integral Molecular and Fierce Biotech – Conquering Undruggable Targets to Obtain Preclinical Antibodies

Thursday, September 14, 2023
8 am PT, 11 am ET, 17:00 CET
Watch the webinar

Despite the remarkable growth of antibody-based therapies in recent years, numerous promising targets remain untapped. Many targets have resisted conventional discovery approaches because they are highly conserved, structurally complex, or they present other technical hurdles. In this webinar, industry experts will share innovative strategies they have used to unlock challenging targets including membrane proteins.

They will discuss:

  • Key questions that scientists should ask before embarking on an antibody discovery campaign
  • How to leverage advancements in immunization—including RNA—to target native epitopes and generate diverse antibodies
  • Strategies for unlocking conserved antibody targets using approaches such as divergent host species
  • Case studies of two challenging targets, claudin 6 and GPRC5D, with a focus on key innovations that led to the discovery of preclinical candidates including CTIM-76, a pre-IND (Investigational New Drug) stage molecule being developed for oncology therapeutics

 

Fierce Life Sciences and Integral Molecular webinar speakers banner

Watch the webinar

Upcoming Events

World Vaccine Congress Washington
April 1st- 4th, 2024 
Washington DC
 
AACR
April 5th- 10th, 2024 
San Diego, CA
 
Festival of Biologics USA
April 15th- 17th, 2024 
San Diego, CA
 
PEGS Boston
May 13th- 17th, 2024 
Boston, MA